15 Jun 2020
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2020/06/15/2048114/0/en/Adamis-Pharmaceuticals-Announces-License-to-Commercialize-Tempol-a-Novel-Investigational-Anti-inflammatory-and-Antioxidant-Drug-for-the-Treatment-of-Respiratory-Diseases-Including-.html